ロード中...
Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
Doxorubicin (DOX), an anthracycline, is broadly considered the most active single agent available for treating breast cancer but has been known to induce cardiotoxicity. Although DOX is highly effective in treating triple-negative breast cancer (TNBC), DOX can have poor outcomes owing to induction o...
保存先:
| 出版年: | Biomed Res Int |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766315/ https://ncbi.nlm.nih.gov/pubmed/26981525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1959270 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|